In conclusion, high TMB can predict an increase in PFS after PD-1/PD-L1 inhibitor treatment for NSCLC, but its predictive value for OS, ORR, and long-term survival requires further research. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.